Conditions: Anemia, Iron-Deficiency Kidney Failure, Chronic
Keywords: Iron deficiency Anemia Chronic kidney disease Erythropoietic agents Sodium Ferric Gluconate Anemia, Iron-Deficiency/drug therapy/etiology Kidney Failure, Chronic/blood/complications/therapy Erythropoietin, Recombinant/adverse effects/therapeutic use
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 52
Healthy volunteers: no

Brief summary:
This study compares the effect of Ferrlecit® (a form of intravenous iron) to ferrous sulfate (a form of oral iron) in treating anemia and iron deficiency in chronic kidney disease patients who are receiving erythropoietic agents, such as Procrit® and Aranesp®.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Sodium Ferric Gluconate complex in sucrose intervention 2: Ferrous sulfate tablets
Intervention descriptions: intervention 1: Sodium ferric gluconate complex in sucrose, 250 mg IV weekly for 4 doses intervention 2: ferrous sulfate 325 mg three times daily for 6 weeks

Protocol document: